Concepts (216)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nuclear Proteins | 26 | 2023 | 696 | 5.740 |
Why?
|
| Membrane Proteins | 20 | 2021 | 1196 | 4.320 |
Why?
|
| Muscular Dystrophy, Emery-Dreifuss | 11 | 2020 | 14 | 4.070 |
Why?
|
| Nuclear Envelope | 14 | 2023 | 36 | 2.530 |
Why?
|
| Cell Nucleus | 16 | 2023 | 579 | 2.260 |
Why?
|
| Muscle Development | 4 | 2020 | 41 | 2.210 |
Why?
|
| Cell Differentiation | 6 | 2020 | 1458 | 1.530 |
Why?
|
| Histone Deacetylases | 3 | 2017 | 63 | 1.440 |
Why?
|
| Nuclear Matrix | 2 | 2021 | 3 | 1.390 |
Why?
|
| Myoblasts | 2 | 2020 | 31 | 1.140 |
Why?
|
| Stem Cells | 2 | 2020 | 351 | 1.120 |
Why?
|
| Transcription Factors | 7 | 2014 | 1565 | 0.970 |
Why?
|
| Lamin Type A | 5 | 2015 | 24 | 0.960 |
Why?
|
| Muscle, Skeletal | 5 | 2020 | 449 | 0.900 |
Why?
|
| MyoD Protein | 2 | 2013 | 15 | 0.870 |
Why?
|
| Nuclear Lamina | 2 | 2013 | 7 | 0.820 |
Why?
|
| LIM Domain Proteins | 4 | 2014 | 25 | 0.800 |
Why?
|
| Dystroglycans | 1 | 2020 | 15 | 0.770 |
Why?
|
| Histone Acetyltransferases | 1 | 2020 | 38 | 0.740 |
Why?
|
| Thiazoles | 1 | 2020 | 131 | 0.700 |
Why?
|
| Mutation | 7 | 2021 | 3968 | 0.670 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 4 | 2013 | 379 | 0.670 |
Why?
|
| Protein Binding | 13 | 2021 | 1456 | 0.640 |
Why?
|
| Cell Movement | 1 | 2021 | 758 | 0.610 |
Why?
|
| Active Transport, Cell Nucleus | 7 | 2020 | 75 | 0.580 |
Why?
|
| Mice | 15 | 2021 | 11352 | 0.570 |
Why?
|
| MAP Kinase Signaling System | 1 | 2017 | 192 | 0.560 |
Why?
|
| Thymopoietins | 6 | 2005 | 7 | 0.550 |
Why?
|
| Animals | 22 | 2021 | 26582 | 0.540 |
Why?
|
| HeLa Cells | 10 | 2020 | 498 | 0.530 |
Why?
|
| Homeodomain Proteins | 2 | 2011 | 536 | 0.520 |
Why?
|
| PAX7 Transcription Factor | 1 | 2013 | 4 | 0.480 |
Why?
|
| Myogenic Regulatory Factor 5 | 1 | 2013 | 3 | 0.480 |
Why?
|
| Cells, Cultured | 4 | 2021 | 2818 | 0.460 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 4 | 2001 | 122 | 0.440 |
Why?
|
| Cell Line | 5 | 2021 | 2468 | 0.440 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2013 | 623 | 0.440 |
Why?
|
| Myoblasts, Skeletal | 1 | 2012 | 3 | 0.430 |
Why?
|
| Ribonucleoproteins | 3 | 2002 | 38 | 0.430 |
Why?
|
| DNA-Binding Proteins | 5 | 2023 | 1208 | 0.410 |
Why?
|
| Calcium-Binding Proteins | 3 | 2002 | 115 | 0.410 |
Why?
|
| Paired Box Transcription Factors | 1 | 2011 | 50 | 0.400 |
Why?
|
| Binding Sites | 7 | 2020 | 1098 | 0.360 |
Why?
|
| Carrier Proteins | 7 | 2002 | 673 | 0.360 |
Why?
|
| Nuclear Matrix-Associated Proteins | 3 | 2016 | 13 | 0.360 |
Why?
|
| Cardiomyopathies | 2 | 2009 | 240 | 0.340 |
Why?
|
| Gene Expression Regulation | 5 | 2014 | 1920 | 0.330 |
Why?
|
| Transcription, Genetic | 5 | 2011 | 1135 | 0.330 |
Why?
|
| Muscular Dystrophies | 4 | 2012 | 54 | 0.310 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2007 | 74 | 0.300 |
Why?
|
| Breast Neoplasms | 1 | 2021 | 2903 | 0.300 |
Why?
|
| MicroRNAs | 1 | 2012 | 534 | 0.300 |
Why?
|
| Neoplasm Metastasis | 2 | 2021 | 1056 | 0.290 |
Why?
|
| Receptors, Glucocorticoid | 3 | 2002 | 120 | 0.290 |
Why?
|
| Multiprotein Complexes | 1 | 2007 | 95 | 0.290 |
Why?
|
| Humans | 28 | 2023 | 86644 | 0.290 |
Why?
|
| Microscopy, Confocal | 2 | 2021 | 268 | 0.280 |
Why?
|
| Neoplasms | 1 | 2021 | 2898 | 0.280 |
Why?
|
| Proteome | 1 | 2007 | 124 | 0.280 |
Why?
|
| Myocardium | 2 | 2008 | 529 | 0.280 |
Why?
|
| Cell Proliferation | 3 | 2021 | 1578 | 0.280 |
Why?
|
| Karyopherins | 3 | 2001 | 14 | 0.270 |
Why?
|
| Lamins | 3 | 2008 | 6 | 0.250 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2007 | 302 | 0.250 |
Why?
|
| Actins | 2 | 2005 | 451 | 0.250 |
Why?
|
| Signal Transduction | 6 | 2014 | 3241 | 0.240 |
Why?
|
| Chromatin | 3 | 2013 | 380 | 0.240 |
Why?
|
| Mice, Knockout | 3 | 2020 | 1924 | 0.240 |
Why?
|
| Genome, Human | 1 | 2008 | 756 | 0.230 |
Why?
|
| Nerve Tissue Proteins | 4 | 2009 | 503 | 0.230 |
Why?
|
| Histones | 2 | 2017 | 311 | 0.220 |
Why?
|
| Actin Cytoskeleton | 1 | 2004 | 192 | 0.220 |
Why?
|
| Cytosol | 2 | 2001 | 189 | 0.210 |
Why?
|
| Mice, Inbred C57BL | 3 | 2020 | 3092 | 0.210 |
Why?
|
| Drosophila Proteins | 2 | 2003 | 488 | 0.200 |
Why?
|
| Transcriptional Activation | 2 | 2013 | 280 | 0.200 |
Why?
|
| Green Fluorescent Proteins | 1 | 2021 | 305 | 0.180 |
Why?
|
| Cell Line, Tumor | 2 | 2021 | 2426 | 0.180 |
Why?
|
| Transplantation, Heterologous | 1 | 2021 | 363 | 0.180 |
Why?
|
| Regeneration | 1 | 2020 | 143 | 0.170 |
Why?
|
| RNA-Binding Proteins | 3 | 2015 | 246 | 0.170 |
Why?
|
| Mice, Nude | 1 | 2021 | 790 | 0.170 |
Why?
|
| Cell Cycle | 1 | 2021 | 502 | 0.170 |
Why?
|
| ran GTP-Binding Protein | 4 | 2002 | 4 | 0.160 |
Why?
|
| Protein Structure, Tertiary | 7 | 2008 | 736 | 0.160 |
Why?
|
| Disease Models, Animal | 3 | 2014 | 2232 | 0.160 |
Why?
|
| Cytoplasm | 3 | 2011 | 281 | 0.160 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2013 | 279 | 0.160 |
Why?
|
| Calcium | 1 | 2002 | 1156 | 0.150 |
Why?
|
| Butadienes | 1 | 2017 | 33 | 0.150 |
Why?
|
| Theophylline | 1 | 2017 | 34 | 0.150 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2017 | 45 | 0.150 |
Why?
|
| Acetylation | 1 | 2017 | 121 | 0.150 |
Why?
|
| Nucleocytoplasmic Transport Proteins | 3 | 2001 | 12 | 0.150 |
Why?
|
| Myosin Heavy Chains | 1 | 2017 | 88 | 0.150 |
Why?
|
| Organ Specificity | 2 | 2008 | 258 | 0.140 |
Why?
|
| Flavonoids | 1 | 2017 | 85 | 0.140 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2017 | 85 | 0.140 |
Why?
|
| Nitriles | 1 | 2017 | 149 | 0.140 |
Why?
|
| Repressor Proteins | 2 | 2013 | 403 | 0.140 |
Why?
|
| Chromatography, Affinity | 2 | 2007 | 81 | 0.140 |
Why?
|
| Imidazoles | 1 | 2017 | 162 | 0.140 |
Why?
|
| B-Lymphocytes | 1 | 2020 | 724 | 0.130 |
Why?
|
| Kinetics | 2 | 2012 | 1513 | 0.130 |
Why?
|
| Neuromuscular Junction Diseases | 1 | 2014 | 3 | 0.130 |
Why?
|
| Muscular Diseases | 1 | 2015 | 63 | 0.130 |
Why?
|
| Pyridines | 1 | 2017 | 310 | 0.130 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2007 | 557 | 0.120 |
Why?
|
| Models, Biological | 2 | 2017 | 1749 | 0.120 |
Why?
|
| Phosphorylation | 1 | 2017 | 1106 | 0.120 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2014 | 222 | 0.120 |
Why?
|
| Muscle Contraction | 1 | 2014 | 283 | 0.120 |
Why?
|
| Calreticulin | 3 | 2002 | 13 | 0.120 |
Why?
|
| Body Weight | 1 | 2014 | 459 | 0.110 |
Why?
|
| Muscle Proteins | 1 | 2013 | 132 | 0.110 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2017 | 589 | 0.110 |
Why?
|
| Cell Membrane | 2 | 2006 | 666 | 0.110 |
Why?
|
| Subcellular Fractions | 1 | 2012 | 93 | 0.110 |
Why?
|
| Cell Membrane Permeability | 3 | 2002 | 119 | 0.110 |
Why?
|
| Genetic Loci | 1 | 2013 | 250 | 0.110 |
Why?
|
| beta Catenin | 1 | 2013 | 251 | 0.110 |
Why?
|
| Heart Diseases | 1 | 2014 | 290 | 0.100 |
Why?
|
| Morpholines | 1 | 2012 | 65 | 0.100 |
Why?
|
| Catalysis | 1 | 2012 | 203 | 0.100 |
Why?
|
| Echocardiography | 2 | 2014 | 911 | 0.100 |
Why?
|
| PAX3 Transcription Factor | 1 | 2011 | 11 | 0.100 |
Why?
|
| Cell Growth Processes | 1 | 2011 | 83 | 0.100 |
Why?
|
| Body Mass Index | 1 | 2014 | 770 | 0.100 |
Why?
|
| Enzyme Activation | 1 | 2012 | 692 | 0.100 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2011 | 316 | 0.090 |
Why?
|
| Phenotype | 2 | 2014 | 2378 | 0.090 |
Why?
|
| Gene Regulatory Networks | 1 | 2012 | 296 | 0.090 |
Why?
|
| Down-Regulation | 1 | 2011 | 504 | 0.090 |
Why?
|
| Genome | 1 | 2012 | 372 | 0.090 |
Why?
|
| Aging, Premature | 1 | 2008 | 7 | 0.080 |
Why?
|
| Atrioventricular Node | 1 | 2008 | 33 | 0.080 |
Why?
|
| Gene Silencing | 1 | 2008 | 172 | 0.080 |
Why?
|
| Epigenesis, Genetic | 1 | 2012 | 479 | 0.080 |
Why?
|
| Promoter Regions, Genetic | 1 | 2011 | 937 | 0.080 |
Why?
|
| Chromatography, Ion Exchange | 1 | 2007 | 34 | 0.080 |
Why?
|
| Chromatography, Gel | 1 | 2007 | 103 | 0.080 |
Why?
|
| Syndrome | 1 | 2008 | 446 | 0.080 |
Why?
|
| Immunoprecipitation | 1 | 2007 | 134 | 0.080 |
Why?
|
| Sequence Homology, Amino Acid | 3 | 2002 | 416 | 0.080 |
Why?
|
| Mutation, Missense | 2 | 2009 | 276 | 0.070 |
Why?
|
| Amino Acid Sequence | 4 | 2004 | 2062 | 0.070 |
Why?
|
| Molecular Sequence Data | 4 | 2008 | 3030 | 0.070 |
Why?
|
| Protein Interaction Mapping | 1 | 2006 | 82 | 0.070 |
Why?
|
| Gene Expression Profiling | 1 | 2012 | 1384 | 0.070 |
Why?
|
| Precipitin Tests | 2 | 2003 | 108 | 0.070 |
Why?
|
| DNA | 2 | 2002 | 1294 | 0.070 |
Why?
|
| Nuclear Pore | 2 | 2002 | 11 | 0.070 |
Why?
|
| Nuclear Localization Signals | 2 | 2002 | 10 | 0.070 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2003 | 179 | 0.070 |
Why?
|
| Protein Biosynthesis | 1 | 2007 | 378 | 0.070 |
Why?
|
| Protein Transport | 1 | 2006 | 411 | 0.060 |
Why?
|
| Gelsolin | 1 | 2004 | 11 | 0.060 |
Why?
|
| Substrate Specificity | 2 | 2002 | 347 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2006 | 689 | 0.060 |
Why?
|
| Apoptosis | 2 | 2008 | 1683 | 0.060 |
Why?
|
| Two-Hybrid System Techniques | 4 | 2004 | 55 | 0.060 |
Why?
|
| Binding, Competitive | 1 | 2002 | 145 | 0.060 |
Why?
|
| Digoxin | 1 | 2002 | 21 | 0.060 |
Why?
|
| A Kinase Anchor Proteins | 1 | 2002 | 2 | 0.050 |
Why?
|
| Cell Compartmentation | 1 | 2002 | 69 | 0.050 |
Why?
|
| Tissue Distribution | 1 | 2002 | 290 | 0.050 |
Why?
|
| Membrane Fusion | 1 | 2002 | 37 | 0.050 |
Why?
|
| Cytoskeletal Proteins | 3 | 2009 | 223 | 0.050 |
Why?
|
| Zinc Fingers | 1 | 2001 | 56 | 0.050 |
Why?
|
| Biological Assay | 1 | 2002 | 78 | 0.050 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2002 | 101 | 0.050 |
Why?
|
| Plants | 1 | 2002 | 112 | 0.050 |
Why?
|
| Biological Transport | 2 | 1999 | 396 | 0.050 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2001 | 28 | 0.050 |
Why?
|
| Endoplasmic Reticulum | 1 | 2002 | 250 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2002 | 879 | 0.050 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2001 | 107 | 0.050 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2002 | 276 | 0.040 |
Why?
|
| Female | 2 | 2021 | 44533 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2002 | 1961 | 0.040 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2015 | 44 | 0.030 |
Why?
|
| Genes, Reporter | 2 | 2003 | 268 | 0.030 |
Why?
|
| DNA, Complementary | 2 | 2003 | 393 | 0.020 |
Why?
|
| Heterochromatin | 1 | 2009 | 22 | 0.020 |
Why?
|
| Laminin | 1 | 2009 | 85 | 0.020 |
Why?
|
| Myocytes, Cardiac | 1 | 2009 | 275 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2009 | 729 | 0.020 |
Why?
|
| RNA, Messenger | 2 | 2003 | 1981 | 0.020 |
Why?
|
| RNA Splicing Factors | 1 | 2003 | 27 | 0.010 |
Why?
|
| Multienzyme Complexes | 1 | 2003 | 64 | 0.010 |
Why?
|
| Time Factors | 2 | 2003 | 5210 | 0.010 |
Why?
|
| Gene Library | 1 | 2003 | 130 | 0.010 |
Why?
|
| Cysteine Endopeptidases | 1 | 2003 | 87 | 0.010 |
Why?
|
| Open Reading Frames | 1 | 2003 | 117 | 0.010 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2003 | 100 | 0.010 |
Why?
|
| Dimerization | 1 | 2002 | 143 | 0.010 |
Why?
|
| Streptavidin | 1 | 2002 | 14 | 0.010 |
Why?
|
| RNA Splicing | 1 | 2003 | 142 | 0.010 |
Why?
|
| COS Cells | 1 | 2001 | 166 | 0.010 |
Why?
|
| Saccharomyces | 1 | 2001 | 21 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 2003 | 989 | 0.010 |
Why?
|
| Guanosine Triphosphate | 1 | 2001 | 38 | 0.010 |
Why?
|
| Gene Products, rev | 1 | 2001 | 1 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 2001 | 177 | 0.010 |
Why?
|
| RNA, Small Nuclear | 1 | 2001 | 32 | 0.010 |
Why?
|
| GTPase-Activating Proteins | 1 | 2001 | 65 | 0.010 |
Why?
|
| Mutagenesis | 1 | 2001 | 199 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 2002 | 242 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2002 | 460 | 0.010 |
Why?
|
| RNA, Transfer | 1 | 2001 | 151 | 0.010 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2002 | 434 | 0.010 |
Why?
|
| RNA | 1 | 2003 | 560 | 0.010 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 1999 | 109 | 0.010 |
Why?
|
| Caenorhabditis elegans | 1 | 1999 | 223 | 0.010 |
Why?
|
| Base Sequence | 1 | 1999 | 2330 | 0.010 |
Why?
|
| Male | 1 | 2008 | 40966 | 0.000 |
Why?
|